Ironwood Pharmaceuticals (IRWD) Receivables (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Receivables of $105.8 million for Q1 2026, up 126.64% sequentially from $46.7 million in Q4 2025, and up 165.93% YoY from $39.8 million in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Receivables (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Receivables for 17 years, with the latest figure at $105.8 million in Q1 2026.
- Quarterly Receivables rose 165.93% year-over-year to $105.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $105.8 million (up 165.93% YoY) and the FY2025 annual result came in at $46.7 million, down 42.98% from the prior year.
- Receivables improved to $105.8 million in Q1 2026 per IRWD's latest filing, from $46.7 million in the prior quarter.
- Over five years, Receivables peaked at $131.0 million in Q3 2022 and troughed at $39.8 million in Q1 2025.
- A 5-year average of $97.5 million and a median of $115.5 million in 2022 frame the typical range for Receivables.
- The sharpest annual moves came in 2024 and 2026: Receivables plunged 51.17% in 2024, then soared 165.93% in 2026.
- Over 5 years, Receivables stood at $115.5 million in 2022, then increased by 11.82% to $129.1 million in 2023, then sank by 36.57% to $81.9 million in 2024, then slumped by 42.97% to $46.7 million in 2025, then jumped by 126.64% to $105.8 million in 2026.
- According to Business Quant data, Receivables over the past three periods registered $105.8 million, $46.7 million, and $120.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 1.08 Bn |
| 10 | Ironwood Pharmaceuticals | 669.95 Mn | 590.82 Mn | - | 112.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 112.73 Mn |
| Mar 31, 2026 | 105.84 Mn |
| Dec 31, 2025 | 46.70 Mn |
| Sep 30, 2025 | 120.40 Mn |
| Jun 30, 2025 | 86.20 Mn |
| Mar 31, 2025 | 39.80 Mn |
| Dec 31, 2024 | 81.89 Mn |
| Sep 30, 2024 | 76.20 Mn |
| Jun 30, 2024 | 58.11 Mn |
| Mar 31, 2024 | 72.00 Mn |
| Dec 31, 2023 | 129.10 Mn |
| Sep 30, 2023 | 124.50 Mn |
| Jun 30, 2023 | 119.00 Mn |
| Mar 31, 2023 | 115.75 Mn |
| Dec 31, 2022 | 115.46 Mn |
| Sep 30, 2022 | 131.00 Mn |
| Jun 30, 2022 | 116.60 Mn |
| Mar 31, 2022 | 119.70 Mn |
| Dec 31, 2021 | 138.00 Mn |
| Sep 30, 2021 | 125.60 Mn |